A citation-based method for searching scientific literature

Lin Lu, Deng-Lei Fu, Hui-Qin Li, Ai-Ju Liu, Ji-Huang Li, Guo-Qing Zheng. PLoS One 2014
Times Cited: 73







List of co-cited articles
794 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
138
43

Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
291
42

Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
167
31

Diabetes and the risk of developing Parkinson's disease in Denmark.
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
120
28

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.
E Cereda, M Barichella, E Cassani, R Caccialanza, G Pezzoli. Neurology 2012
92
28

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Mark L Wahlqvist, Meei-Shyuan Lee, Chih-Cheng Hsu, Shao-Yuan Chuang, Jiunn-Tay Lee, Hsin-Ni Tsai. Parkinsonism Relat Disord 2012
149
27

Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
106
26

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
354
26

Shared dysregulated pathways lead to Parkinson's disease and diabetes.
Jose A Santiago, Judith A Potashkin. Trends Mol Med 2013
139
24

Obesity, diabetes, and risk of Parkinson's disease.
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
100
24

Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study.
Ruth Brauer, Krishnan Bhaskaran, Nishi Chaturvedi, David T Dexter, Liam Smeeth, Ian Douglas. PLoS Med 2015
82
24


Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
80
23

Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
125
21

Exenatide and the treatment of patients with Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Clin Invest 2013
286
21

Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Iciar Aviles-Olmos, Patricia Limousin, Andrew Lees, Thomas Foltynie. Brain 2013
189
20



Increased risk of Parkinson disease with diabetes mellitus in a population-based study.
Yu-Wan Yang, Teng-Fu Hsieh, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Jen-Huai Chiang, Tsai-Chung Li, Cheng-Chieh Lin. Medicine (Baltimore) 2017
62
22

Diabetes is associated with postural instability and gait difficulty in Parkinson disease.
Vikas Kotagal, Roger L Albin, Martijn L T M Müller, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen. Parkinsonism Relat Disord 2013
63
20

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
112
17

Dementia is associated with insulin resistance in patients with Parkinson's disease.
Domenico Bosco, Massimiliano Plastino, Dario Cristiano, Carmela Colica, Caterina Ermio, Matteo De Bartolo, Pasquale Mungari, Giulia Fonte, Domenico Consoli, Arturo Consoli,[...]. J Neurol Sci 2012
83
16

Diabetes preceding Parkinson's disease onset. A case-control study.
Marco D'Amelio, Paolo Ragonese, Graziella Callari, Norma Di Benedetto, Barbara Palmeri, Valeria Terruso, Giuseppe Salemi, Giorgia Famoso, Paolo Aridon, Giovanni Savettieri. Parkinsonism Relat Disord 2009
50
24

Diabetes and risk of Parkinson's disease.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Mov Disord 2013
35
34

Association between Parkinson's disease and diabetes: Data from NEDICES study.
E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
37
32

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Joshua Kahan, Peter Ell, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Parkinsons Dis 2014
166
15


Meta-analysis of early nonmotor features and risk factors for Parkinson disease.
Alastair J Noyce, Jonathan P Bestwick, Laura Silveira-Moriyama, Christopher H Hawkes, Gavin Giovannoni, Andrew J Lees, Anette Schrag. Ann Neurol 2012
395
15

Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study.
Per Svenningsson, Karin Wirdefeldt, Li Yin, Fang Fang, Ioanna Markaki, Suad Efendic, Jonas F Ludvigsson. Mov Disord 2016
42
26

Diabetes mellitus and Parkinson disease.
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
95
13

Metabolic markers or conditions preceding Parkinson's disease: a case-control study.
Rodolfo Savica, Brandon R Grossardt, J Eric Ahlskog, Walter A Rocca. Mov Disord 2012
33
27


Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.
Yoshihiro Miyake, Keiko Tanaka, Wakaba Fukushima, Satoshi Sasaki, Chikako Kiyohara, Yoshio Tsuboi, Tatsuo Yamada, Tomoko Oeda, Takami Miki, Nobutoshi Kawamura,[...]. J Neurol Sci 2010
87
12

Insulin and neurodegenerative disease: shared and specific mechanisms.
Suzanne Craft, G Stennis Watson. Lancet Neurol 2004
585
12

Glitazone use associated with reduced risk of Parkinson's disease.
Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
64
14

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Bin Zheng, Zhixiang Liao, Joseph J Locascio, Kristen A Lesniak, Sarah S Roderick, Marla L Watt, Aron C Eklund, Yanli Zhang-James, Peter D Kim, Michael A Hauser,[...]. Sci Transl Med 2010
542
10

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
Laura Dunn, George Fg Allen, Adamantios Mamais, Helen Ling, Abi Li, Kate E Duberley, Iain P Hargreaves, Simon Pope, Janice L Holton, Andrew Lees,[...]. Neurobiol Aging 2014
130
10

Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study.
Giulio Scigliano, Massimo Musicco, Paola Soliveri, Immacolata Piccolo, Gabriele Ronchetti, Floriano Girotti. Stroke 2006
142
10

Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.
Karen M Powers, Terri Smith-Weller, Gary M Franklin, W T Longstreth, Phillip D Swanson, Harvey Checkoway. Parkinsonism Relat Disord 2006
65
12

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
407
10

Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
S P Patil, P D Jain, P J Ghumatkar, R Tambe, S Sathaye. Neuroscience 2014
160
10

The prevalence of Parkinson's disease: a systematic review and meta-analysis.
Tamara Pringsheim, Nathalie Jette, Alexandra Frolkis, Thomas D L Steeves. Mov Disord 2014
988
10

Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
10

Body Mass Index and Risk of Parkinson's Disease: A Dose-Response Meta-Analysis of Prospective Studies.
Yun-Liang Wang, Yu-Tong Wang, Jin-Feng Li, Yu-Zheng Zhang, Hong-Lei Yin, Bing Han. PLoS One 2015
35
22

Epidemiology of Parkinson's disease.
Lonneke M L de Lau, Monique M B Breteler. Lancet Neurol 2006
10

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
10

Diabetes in patients with idiopathic Parkinson's disease.
Claudia Becker, Gunnar P Brobert, Saga Johansson, Susan S Jick, Christoph R Meier. Diabetes Care 2008
50
16

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
10

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
Kelly Claire Simon, Honglei Chen, Michael Schwarzschild, Alberto Ascherio. Neurology 2007
165
10

Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice.
Ling Wang, Ying-Qi Zhai, Li-Li Xu, Chen Qiao, Xiu-Lan Sun, Jian-Hua Ding, Ming Lu, Gang Hu. Exp Neurol 2014
65
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.